DKK1 and Alzheimer disease: Decreased Wnt/β-catenin signaling, through reduced levels of β-catenin itself or increased levels of Wnt inhibitors like DKK1, has been observed in both familial (early-onset) and sporadic (late-onset) forms of AD [42, 43].